Medicinal health agent for preventing and treating canine/feline magnesium ammonium phosphate stones

Abstract

The invention relates to a medicinal health agent for preventing and treating canine / feline magnesium ammonium phosphate stones, which is characterized in that the agent is prepared by evenly mixing the following effective components in ratio by weight or unit: 100 to 500 mg of acetohydroxamic acid, 1,000 to 4,000 mg of methenamine and 4,000 IU of vitamin A. The medicinal health agent for preventing and treating canine / feline magnesium ammonium phosphate stones is added as a unit for each kilogram of canine / feline feed. The agent utilizes the characteristic of inhibiting urease activity through acetohydroxamic acid to reduce the ammonia concentration and pH of urine and prevent the formation of infectious urinary stones or inhibit the growth thereof, utilizes the methenamine to kill pathogens and maintain urine acidity so as to destroy the conditions of crystal formation, and utilizes the vitamin A to maintain the integrity of urinary-tract epithelium so as to realize the activity of crystallization inhibitors and inhibit crystallization. The agent is reasonable in compatibility, jointly uses medicaments from different angles to eliminate the inducing factors of stones, and plays adefinite role in preventing magnesium ammonium phosphate stones after the agent is added to canine / feline diets. The agent has the advantages of simple preparation, remarkable effects and wide application range.

Description

technical field [0001] The invention relates to a health-care agent added to feed, in particular to a medicinal health-care agent added to feed for preventing and treating calculus of ammonium magnesium phosphate in dogs and cats. Background technique [0002] In recent years, dogs and cats have become the mainstream of pets, and working dogs and meat dogs have driven the development of the entire dog industry. In the breeding and management of dogs and cats, disease is the most important link that affects the health of dogs and cats. Among them, dog and cat urolithiasis is the most common urinary system disease. According to domestic and foreign research data, its clinical incidence rate is 0.5-1.0%, and the recurrence rate of urolithiasis can be as high as 50% within two years after treatment. Stones can be divided into: ammonium magnesium phosphate stones, calcium oxalate stones and urate stones according to their composition. The most common calculus in dog and cat vet...

AI Technical Summary

Problems solved by technology

Now the Hill Company in the United States has developed a series of prescription diets for the prevention and treatment of dog and cat stones, but the general price is relatively high, and it is difficult to widely promote them.